Moleculin Biotech Inc. (NASDAQ: MBRX) started the day on January 12, 2021, with a price decrease of -5.88% at $0.96. During the day, the stock rose to $1.02 and sunk to $0.92 before settling in for the price of $1.02 at the close. Taking a more long-term approach, MBRX posted a 52-week range of $0.32-$1.97.
Meanwhile, its Annual Earning per share during the time was -20.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 29.30%. This publicly-traded company’s shares outstanding now amounts to $61.48 million, simultaneously with a float of $55.49 million. The organization now has a market capitalization sitting at $56.37 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8047, while the 200-day Moving Average is $0.8831.
Moleculin Biotech Inc. (MBRX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Moleculin Biotech Inc.’s current insider ownership accounts for 1.70%, in contrast to 21.80% institutional ownership.
Moleculin Biotech Inc. (MBRX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.06 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.09) by $0.03. This company achieved a return on equity of -88.50. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Moleculin Biotech Inc.’s EPS increase for this current 12-month fiscal period is 29.30% and is forecasted to reach -0.36 in the upcoming year.
Moleculin Biotech Inc. (NASDAQ: MBRX) Trading Performance Indicators
Let’s observe the current performance indicators for Moleculin Biotech Inc. (MBRX). It’s Quick Ratio in the last reported quarter now stands at 4.40. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, MBRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.33, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.36 at the market close of one year from today.
Technical Analysis of Moleculin Biotech Inc. (MBRX)
If we take a close look at the recent performances of Moleculin Biotech Inc. (NASDAQ: MBRX), its last 5-days Average volume was 3.8 million that shows progress from its year to date volume of 3.39 million. During the previous 9 days, stock’s Stochastic %D was recorded 68.25% While, its Average True Range was 0.0804.
Raw Stochastic average of Moleculin Biotech Inc. (MBRX) in the period of the previous 100 days is set at 54.18%, which indicates a major fall in contrast to 58.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 74.49% that was higher than 73.83% volatility it exhibited in the past 100-days period.